InvestorsHub Logo
Followers 32
Posts 3746
Boards Moderated 0
Alias Born 07/02/2004

Re: matthewverymuch post# 9097

Saturday, 05/28/2016 8:41:06 PM

Saturday, May 28, 2016 8:41:06 PM

Post# of 16911
Shows great leadership from the true leader of Probuphine.

Could not agree more. IMO part of the sluggishness in the PPS on Friday following approval comes from a lack of confidence in TTNP management itself. The reality is that it took Braeburn to get Probuphine over the FDA approval line. What's now left in the TTNP pipeline?

Braeburn has a vision for success, but more importantly, they have a clear plan for getting there. The fact that Sunil and co are attached to Braeburn via royaly payments could very well be TTNP's saving grace. After all, with Probuphine approval in the bag, who's going to buy into TTNP for their exciting, well-planned next project (he said sarcastically)...Alzheimers or whatever it might turn out to be.
And based on the TTNP track record, is there any doubt that Sunil can spend through those Braeburn royalty payments quicker than shit through a goose whilst he banks a hefy paycheck?

IMO, a buyout at any price over $15 would be a happy ending to this story fort those of us still holding. As I consider the revenue projections around Probuphine, I can only wish that I had shares in a publically traded Braeburn rather than TTNP.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News